
Acquired Thrombotic Thrombocytopenic Purpura (aTTP) - WebMD
Oct 3, 2024 · Acquired thrombotic thrombocytopenic purpura (acquired TTP, or aTTP) is a rare blood disorder that results in blood clots in small blood vessels around your body. These clots can slow the...
Thrombotic Thrombocytopenic Purpura: Symptoms & Treatment
Feb 9, 2022 · Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder in which thrombi (blood clots) form in small blood vessels throughout your body. These blood clots can restrict the flow of oxygen-rich blood to your organs, causing a number of life-limiting complications. Treatments include plasma therapy, medication and surgery.
ATTP - Global Standards in Knowledge & Technology Transfer
Founded in 2010 by four prominent national and international technology transfer associations, the Alliance of Technology Transfer Professionals (ATTP) is dedicated to advancing the professionalism of tech transfer practitioners worldwide.
Just In
Rush International Trauma and Public Health Training Program: FY24, Illinois, Colorado, Guam, Michigan, and Pennsylvania conducted high-level, joint training at Rush with their SPP nations. Pass this valuable medical exchange and training opportunity to your State HQ SPP Manager.
Acquired thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura (TTP), acquired is a blood disorder characterized by low platelets (i.e., thrombocytopenia), small areas of bleeding under the skin (i.e., purpura), low red blood cell count, and hemolytic anemia. TTP causes blood clots (thrombi) to form in small blood vessels throughout the body.
What Is Acquired Thrombotic Thrombocytopenic Purpura (aTTP)?
Dec 7, 2022 · What Is Acquired Thrombotic Thrombocytopenic Purpura? Symptoms, Causes, Diagnosis, Treatment, and Prevention. Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disorder in...
Treatment of acquired thrombotic thrombocytopenic purpura …
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life‐threatening autoimmune thrombotic microangiopathy. Current standard of care is therapeutic plasma exchange, immunosuppression, and caplacizumab, an anti‐von Willebrand factor nanobody, which is effective in treating aTTP episodes.
What is aTTP/iTTP? - CABLIVI (caplacizumab-yhdp) Patient Site
aTTP is a rare, life-threatening blood disorder that causes small clots throughout the body. aTTP is also known as immune-mediated thrombotic thrombocytopenic purpura (iTTP). aTTP and iTTP are the same condition.
Diagnosing aTTP/iTTP | CABLIVI (caplacizumab-yhdp) for HCPs
Acquired/immune-mediated thrombotic thrombocytopenic purpura (aTTP/iTTP) is a rare, rapidly progressing, life-threatening medical emergency. It has been reported in literature that, when left untreated, death may occur in up to 90% of patients with aTTP/iTTP, making urgent diagnosis and treatment a necessity. 1-6
acquired thrombotic thrombocytopenic purpura - National Cancer Institute
Also called aTTP. A rare condition in which blood clots form in small blood vessels throughout the body. These clots can block the flow of blood and oxygen to the body’s organs, which leads to a lower-than-normal number of platelets in the blood.
- Some results have been removed